These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38219820)

  • 41. Familial combined hypolipidemia: angiopoietin-like protein-3 deficiency.
    Arca M; D'Erasmo L; Minicocci I
    Curr Opin Lipidol; 2020 Apr; 31(2):41-48. PubMed ID: 32022755
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins.
    Huang Y; Liu XQ; Rall SC; Mahley RW
    J Biol Chem; 1998 Jul; 273(28):17483-90. PubMed ID: 9651338
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Angiopoietin-like protein 3, an emerging cardiometabolic therapy target with systemic and cell-autonomous functions.
    Ruhanen H; Haridas PAN; Jauhiainen M; Olkkonen VM
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Dec; 1865(12):158791. PubMed ID: 32777482
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice.
    Véniant MM; Zlot CH; Walzem RL; Pierotti V; Driscoll R; Dichek D; Herz J; Young SG
    J Clin Invest; 1998 Oct; 102(8):1559-68. PubMed ID: 9788969
    [TBL] [Abstract][Full Text] [Related]  

  • 45.
    Pennisi G; Maurotti S; Ciociola E; Jamialahmadi O; Bertolazzi G; Mirarchi A; Bergh PO; Scionti F; Mancina RM; Spagnuolo R; Tripodo C; Boren J; Petta S; Romeo S
    Arterioscler Thromb Vasc Biol; 2024 May; 44(5):1086-1097. PubMed ID: 38385290
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase.
    Chi X; Britt EC; Shows HW; Hjelmaas AJ; Shetty SK; Cushing EM; Li W; Dou A; Zhang R; Davies BSJ
    Mol Metab; 2017 Oct; 6(10):1137-1149. PubMed ID: 29031715
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of the LDL receptor in apolipoprotein B secretion.
    Twisk J; Gillian-Daniel DL; Tebon A; Wang L; Barrett PH; Attie AD
    J Clin Invest; 2000 Feb; 105(4):521-32. PubMed ID: 10683382
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transcriptomic therapy for dyslipidemias utilizing nucleic acids targeted at ANGPTL3.
    Watts GF; Raal FJ; Chan DC
    Future Cardiol; 2022 Feb; 18(2):143-153. PubMed ID: 34651521
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel nanobody-heavy chain antibody against Angiopoietin-like protein 3 reduces plasma lipids and relieves nonalcoholic fatty liver disease.
    Hu X; Fan J; Ma Q; Han L; Cao Z; Xu C; Luan J; Jing G; Nan Y; Wu T; Zhang Y; Wang H; Zhang Y; Ju D
    J Nanobiotechnology; 2022 May; 20(1):237. PubMed ID: 35590366
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of microRNA-378a-3p biogenesis promotes hepatic secretion of VLDL and hyperlipidemia by modulating ApoB100-Sortilin1 axis.
    Zhang T; Shi H; Liu N; Tian J; Zhao X; Steer CJ; Han Q; Song G
    Theranostics; 2020; 10(9):3952-3966. PubMed ID: 32226531
    [No Abstract]   [Full Text] [Related]  

  • 51. ANGPTL3 Deficiency and Risk of Hepatic Steatosis.
    D'Erasmo L; Di Martino M; Neufeld T; Fraum TJ; Kang CJ; Burks KH; Di Costanzo A; Minicocci I; Bini S; Maranghi M; Pigna G; Labbadia G; Zheng J; Fierro D; Montali A; Ceci F; Catalano C; Davidson NO; Lucisano G; Nicolucci A; Arca M; Stitziel NO
    Circulation; 2023 Nov; 148(19):1479-1489. PubMed ID: 37712257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Differential expressions of lipid metabolism related genes in the liver of young apoE knockout mice].
    Ye HY; Yin M; Shang YJ; Dai XD; Zhang SQ; Jing W; Du HQ; Zhang L; Pan J
    Sheng Li Xue Bao; 2008 Feb; 60(1):51-8. PubMed ID: 18288358
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phosphatase and tensin homolog (PTEN) regulates hepatic lipogenesis, microsomal triglyceride transfer protein, and the secretion of apolipoprotein B-containing lipoproteins.
    Qiu W; Federico L; Naples M; Avramoglu RK; Meshkani R; Zhang J; Tsai J; Hussain M; Dai K; Iqbal J; Kontos CD; Horie Y; Suzuki A; Adeli K
    Hepatology; 2008 Dec; 48(6):1799-809. PubMed ID: 19026012
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ANGPTL3 and ApoC-III inhibitors for treating hypertriglyceridemia in context: horses for courses?
    Chan DC; Watts GF
    Curr Opin Lipidol; 2024 Jun; 35(3):101-109. PubMed ID: 38372218
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Upregulation of liver VLDL receptor and FAT/CD36 expression in LDLR-/- apoB100/100 mice fed trans-10,cis-12 conjugated linoleic acid.
    Degrace P; Moindrot B; Mohamed I; Gresti J; Du ZY; Chardigny JM; Sébédio JL; Clouet P
    J Lipid Res; 2006 Dec; 47(12):2647-55. PubMed ID: 16957181
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ANGPTL3 is a novel HDL component that regulates HDL function.
    Yang L; Wang Y; Xu Y; Li K; Yin R; Zhang L; Wang D; Wei L; Lang J; Cheng Y; Wang L; Ke J; Zhao D
    J Transl Med; 2024 Mar; 22(1):263. PubMed ID: 38462608
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides.
    Graham MJ; Lee RG; Brandt TA; Tai LJ; Fu W; Peralta R; Yu R; Hurh E; Paz E; McEvoy BW; Baker BF; Pham NC; Digenio A; Hughes SG; Geary RS; Witztum JL; Crooke RM; Tsimikas S
    N Engl J Med; 2017 Jul; 377(3):222-232. PubMed ID: 28538111
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of APOC3 Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism.
    Reyes-Soffer G; Sztalryd C; Horenstein RB; Holleran S; Matveyenko A; Thomas T; Nandakumar R; Ngai C; Karmally W; Ginsberg HN; Ramakrishnan R; Pollin TI
    Arterioscler Thromb Vasc Biol; 2019 Jan; 39(1):63-72. PubMed ID: 30580564
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
    Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel fully human anti-NT-ANGPTL3 antibody from phage display library exhibits potent ApoB, TG, and LDL-C lowering activities in hyperlipidemia mice.
    Zhang P; Wang K; Hu T; Xu M; You X; Chen M; Tang X; Hu H; Jiang Y; Zhao W; Tan S
    FASEB J; 2024 Jan; 38(1):e23399. PubMed ID: 38174870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.